Viberzi is approved by the Food and Drug Administration (FDA) to treat irritable bowel syndrome (IBS) with diarrhea. Viberzi is also referred to by its drug name, Eluxadoline.
Viberzi is an antidiarrheal medication. Viberzi is believed to work by modulating the nerves in the intestines, making them less sensitive and slowing the movement of food through the gut.
How do I take it?
Prescribing information states that Viberzi is taken twice daily.
Viberzi comes in tablet form.
The FDA-approved label for Viberzi lists common side effects including nausea, constipation, and abdominal pain.
Rare but serious side effects listed for Viberzi include pancreatitis and spasm in the sphincter of Oddi, the valve through which bile is secreted into the intestines.
For more details about this treatment, visit:
Viberzi.com – Allergan: http://www.viberzi.com/